Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Gijsen
Pcn269 - Healthcare Resource Use (Hru) Associated With Treatment in Adults With Philadelphia Chromosome-Positive (Ph+) Relapsed or Refractory (R/R) B-Cell Precursor (Bcp) Acute Lymphoblastic Leukemia (All) in Eu-4 Countries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Forward-Backward Multiplicity Correlations in P-Collisions At
Physics Letters, Section B: Nuclear, Elementary Particle and High-Energy Physics
High Energy Physics
Nuclear
Related publications
Therapy With Imatinib Mesylate (Glivec) Preceding Allogeneic Stem Cell Transplantation (SCT) in Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) Among Adults With Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) Achieving Remission With Blinatumomab
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Pcn142 - Cost-Effectiveness Analysis of Inotuzumab Ozogamicin for the Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Bulgaria
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn71 - Budget Impact Analysis of Inotuzumab Ozogamicin for the Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Bulgaria
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn77 - Budget Impact Analysis of Blinatumomab for the Treatment of Pediatric Patients With Philadelphia Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Mexico
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effective Re-Induction Therapy With Dasatinib and Clofarabine in Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Drugs and Therapy Studies
A Novel BCR-ABL1 Mutation in a Patient With Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia
OncoTargets and Therapy
Oncology
Pharmacology
Impact of IKZF1 Deletions on IKZF1 Expression and Outcome in Philadelphia Chromosome Negative Childhood BCP-ALL. Reply to "Incidence and Biological Significance of IKZF1/Ikaros Gene Deletions in Pediatric Philadelphia Chromosome Negative and Philadelphia Chromosome Positive B-Cell Precursor Acute Lymphoblastic Leukemia"
Haematologica
Hematology
Current Paradigms in the Management of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Adults
American Journal of Hematology
Hematology
